undefined undefined
NaN.000
NaN.00%
Xenon Pharmaceuticals (XENE) has released an update. Xenon Pharmaceuticals high...
04-16 21:08
Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and maintains $62 price target.
04-12 19:03
Xenon Pharmaceuticals (XENE) has released an update. Xenon Pharmaceuticals Inc....
04-10 21:08
12月31日,Xenon制药(XENE.US)公布财报,公告显示公司2023财年净利润为-1.82亿美元,同比减少45.60%;其中营业收入为0.00美元,每股...
03-09 00:19
Key Insights Xenon Pharmaceuticals' estimated fair value is US$38.06 based on...
03-03 20:59
Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.64) per sh...
03-01 05:03
Xenon Pharmaceuticals Anticipates Having Sufficient Cash To Fund Operations Int...
03-01 05:03
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
02-29 18:15
Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset Kv7-7000's Phase 3 trial this year, reducing late-stage risks.
02-17 02:58
生物科技投资者看好小盘股,对中盘股的乐观情绪也逐渐升温,并认为Fusion和Merus最有可能在今年跑赢大盘。
02-05 07:37